WO2002040698A3 - Analysis of soluble factor biological markers - Google Patents

Analysis of soluble factor biological markers Download PDF

Info

Publication number
WO2002040698A3
WO2002040698A3 PCT/US2001/043583 US0143583W WO0240698A3 WO 2002040698 A3 WO2002040698 A3 WO 2002040698A3 US 0143583 W US0143583 W US 0143583W WO 0240698 A3 WO0240698 A3 WO 0240698A3
Authority
WO
WIPO (PCT)
Prior art keywords
analysis
biological markers
soluble factor
factor biological
microparticles
Prior art date
Application number
PCT/US2001/043583
Other languages
French (fr)
Other versions
WO2002040698A2 (en
Inventor
Rajendra Singh
Remy Cromer
Original Assignee
Surromed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Surromed Inc filed Critical Surromed Inc
Priority to AU2002237662A priority Critical patent/AU2002237662A1/en
Publication of WO2002040698A2 publication Critical patent/WO2002040698A2/en
Publication of WO2002040698A3 publication Critical patent/WO2002040698A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means

Abstract

Multiplexed bioassays of soluble factors by flow cytometry and associated methods and reagents are provided, including the use of trigger microparticles and detection microparticles to form complexes with soluble factors, and methods of detecting and quantitating the complexes in flow cytometer-based, multiplexed assays.
PCT/US2001/043583 2000-11-17 2001-11-15 Analysis of soluble factor biological markers WO2002040698A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002237662A AU2002237662A1 (en) 2000-11-17 2001-11-15 Analysis of soluble factor biological markers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71586500A 2000-11-17 2000-11-17
US09/715,865 2000-11-17

Publications (2)

Publication Number Publication Date
WO2002040698A2 WO2002040698A2 (en) 2002-05-23
WO2002040698A3 true WO2002040698A3 (en) 2002-08-22

Family

ID=24875788

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/043583 WO2002040698A2 (en) 2000-11-17 2001-11-15 Analysis of soluble factor biological markers

Country Status (2)

Country Link
AU (1) AU2002237662A1 (en)
WO (1) WO2002040698A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018495A1 (en) * 2002-07-24 2004-01-29 Xing-Xiang Li Microparticle based signal amplification for the detection of analytes
AU2003903417A0 (en) 2003-07-04 2003-07-17 Genera Biosystems Pty Ltd Multiplex detection
US20050191665A1 (en) * 2003-12-29 2005-09-01 Xing Su Composite organic-inorganic nanoclusters
US7361410B2 (en) 2003-12-29 2008-04-22 Intel Corporation External modification of composite organic inorganic nanoclusters comprising raman active organic compound
WO2005071401A2 (en) * 2004-01-15 2005-08-04 Chiron Corporation Homogeneous multiplex assay for nucleic acid targets
US7776547B2 (en) 2004-08-26 2010-08-17 Intel Corporation Cellular analysis using Raman surface scanning
US7285427B2 (en) 2004-10-06 2007-10-23 General Electric Company Raman-active particles and methods of making and using them
JP4988578B2 (en) * 2004-10-12 2012-08-01 ルミネックス コーポレーション Method for changing the surface properties of microspheres
WO2006060872A1 (en) 2004-12-10 2006-06-15 Genera Biosystems Pty Ltd Human papilloma virus (hpv) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (facs)
US9201065B2 (en) 2005-11-12 2015-12-01 Platform Diagnostics Limited Agglutination assay

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891656A (en) * 1992-09-14 1999-04-06 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US6337184B1 (en) * 1997-04-01 2002-01-08 Jeffrey B. Miller Molecular marker for muscle stem cells
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
US5891656A (en) * 1992-09-14 1999-04-06 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US6337184B1 (en) * 1997-04-01 2002-01-08 Jeffrey B. Miller Molecular marker for muscle stem cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FULTON ET AL.: "Advanced multiplexed analysis with the flowmetrix TM system", CLINICAL CHEMISTRY, vol. 43, no. 9, 19 June 1997 (1997-06-19), pages 1749 - 1750 *

Also Published As

Publication number Publication date
WO2002040698A2 (en) 2002-05-23
AU2002237662A1 (en) 2002-05-27

Similar Documents

Publication Publication Date Title
WO2002077604A3 (en) Labeled cells for use as an internal functional control in rare cell detection assays
WO2002004918A3 (en) Nanoporous membrane immunosensor
AU1038402A (en) Assay for directly detecting a rs virus related biological cell in a body fluid sample
WO2001018252A3 (en) Methods for disease detection
CA2285918A1 (en) Methods for concentrating ligands using magnetic particles
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
WO2003062787A3 (en) Bioassay and biomolecular identification, sorting, and collection methods using magnetic microspheres
EP1624307A3 (en) Assay for detecting glycated or glycosylated haemoglobin (HbA1c)
AU1461702A (en) Microvolume immunoabsorbant assays with amplified electrochemical detection
WO2004046164A3 (en) Unique recognition sequences and methods of use thereof in protein analysis
PT1409984E (en) Methods and reagents for detecting endotoxin
WO2002040698A3 (en) Analysis of soluble factor biological markers
WO2002094778A3 (en) Peptide conjugates and fluorescence detection methods for intracellular caspase assay
WO2002001230A3 (en) Rapid and sensitive detection of protein aggregation
WO2007063326A3 (en) Assay device and method
WO2006029302A3 (en) Dioxetane-nanoparticle assemblies for energy transfer detection systems, methods of making the assemblies, and methods of using the assemblies in bioassays
WO2002059599A3 (en) System and method for in vitro analysis of therapeutic agents
WO2000017334A3 (en) Analysis of ligand activated nuclear receptors i(in vivo)
WO2001086285A3 (en) Direct detection of individual molecules
WO2006105409A3 (en) Multiplex assay systems
BRPI0409526A (en) processes for detecting an analyte
CA2407760A1 (en) Methods for diagnosis of low grade astrocytoma
WO2003043524A3 (en) Compositions and methods for accurate early pregnancy diagnosis
WO2002073214A3 (en) Novel reagents for detecting cannabinoids
WO2001085779A3 (en) Protein complexes and assays for screening anti-cancer agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP